DMF Medical Incorporated is a Canadian-based corporation founded in 2011. Our team develops technologies to support the delivery of safe, sustainable, and cost-effective anesthesia. We are grounded in the belief that meaningful research and product development leads to improved clinical practice and outcomes.
Our lead product – memsorb™ – is the next-generation solution for CO2 removal in anesthesia circuits.
If you would like more information about memsorb™, please fill out the form below and we will have someone follow up with you.